Search clinical trials for: GIFOX-Bortezomib
Total 924 results
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, Canada, Spain, Israel, United Kingdom, Germany, Austria, Belgium, France, Italy, Ireland, Netherlands, Sweden
-
Millennium Pharmaceuticals, Inc.CompletedNon-Small Cell Lung CancerUnited States
-
Millennium Pharmaceuticals, Inc.CompletedColorectal CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedMalignant Neoplasm | Hepatic ComplicationsUnited States
-
The Methodist Hospital Research InstituteWithdrawnNon-Hodgkin Lymphoma
-
National Cancer Institute (NCI)CompletedAdvanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States
-
Columbia UniversityUnknownMesotheliomaUnited States
-
National Cancer Institute (NCI)TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States
-
Aptium Oncology Research NetworkMillennium Pharmaceuticals, Inc.UnknownNon-small Cell Lung CancerUnited States
-
Fondazione EMN Italy OnlusCompleted
-
Hackensack Meridian HealthCompletedMultiple MyelomaUnited States
-
Emory UniversityMillennium Pharmaceuticals, Inc.; Ortho Biotech, Inc.CompletedProtocol of the Combination of Bortezomib and Tipifarnib for Relapsed or Refractory Multiple MyelomaMultiple MyelomaUnited States, Canada
-
National Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
Georgetown UniversityMillennium Pharmaceuticals, Inc.TerminatedColorectal CancerUnited States
-
Spectrum Health HospitalsMillennium Pharmaceuticals, Inc.CompletedHematological MalignancyUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)CompletedStage III Multiple Myeloma | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse... and other conditionsUnited States
-
Peking Union Medical College HospitalCompletedAutoimmune Hemolytic Anemia | Autoimmune Hemolytic Anemia and Autoimmune ThrombocytopeniaChina
-
National Cancer Institute (NCI)CompletedHead and Neck Cancer | Laryngeal Cancer | Oral Cancer | Carcinoma, Squamous | Pharyngeal CancerUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedSarcoma | Kidney Cancer | Breast Cancer | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)CompletedChildhood Acute Promyelocytic Leukemia (M3) | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Myeloid Leukemia | Blastic Phase Chronic Myelogenous LeukemiaUnited States
-
Massachusetts General HospitalBayer; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsCompletedMelanomaUnited States
-
Rush University Medical CenterGlaxoSmithKline; Millennium Pharmaceuticals, Inc.Terminated
-
Baylor Research InstituteRecruiting
-
National Cancer Institute (NCI)CompletedMantle Cell Lymphoma | Lymphoma, Mantle CellUnited States
-
Seoul National University HospitalRecruitingRelapsed/Refractory Immune ThrombocytopeniaKorea, Republic of
-
Oregon Health and Science UniversityMillennium: The Takeda Oncology CompanyCompletedMultiple Myeloma | Heart Failure, Systolic | Cardiotoxins
-
Janssen-Cilag G.m.b.HCompletedMultiple MyelomaGermany
-
Christian Medical College, Vellore, IndiaUnknownRelapsed Acute Promyelocytic LeukemiaIndia
-
University of BolognaCompleted
-
NCIC Clinical Trials GroupCompleted
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedPrimary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); GlaxoSmithKlineTerminatedWaldenström MacroglobulinemiaUnited States
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedStudy of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaFrance, United States, Spain, Korea, Republic of, Australia, Israel, India, Thailand, China, Czech Republic, Belgium, New Zealand, Russian Federation, Finland, South Africa, United Kingdom, Italy, Brazil, Hungary, Puerto Rico, A... and more
-
Fuzhou General HospitalTerasaki FoundationUnknownRenal Transplantation | UremiaChina
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult... and other conditionsUnited States
-
Mayo ClinicCompletedRefractory Multiple MyelomaUnited States
-
University Hospital, ToulouseCelgene Corporation; Janssen-Cilag Ltd.Completed
-
University of UtahRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Peking Union Medical College HospitalActive, not recruiting
-
Lymphoma Study AssociationJanssen-Cilag International NVTerminatedFollicular LymphomaFrance, Belgium
-
Millennium Pharmaceuticals, Inc.Completed
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)Completed
-
University of Massachusetts, WorcesterGenentech, Inc.; Millennium Pharmaceuticals, Inc.TerminatedLung CancerUnited States
-
Peking University First HospitalRecruitingMultiple Myeloma | Renal InjuryChina
-
Mehrdad Abedi, MDMillennium Pharmaceuticals, Inc.CompletedGraft Versus Host DiseaseUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
University Hospital, ToulouseIntergroupe Francophone du MyelomeCompletedMultiple MyelomaFrance